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ACOUSTIC VOICE ASSESSMENT IN
PARKINSON’S DISEASE PATIENTS SUBMITTED
TO POSTEROVENTRAL PALLIDOTOMY
Lucia Figueiredo Mourão1, Patrícia Maria de Carvalho Aguiar2,
Fernando Antônio Patriani Ferraz3, Mara Suzana Behlau4,Henrique Ballalai Ferraz5
ABSTRACT - Long-term complications in levodopa treated Parkinson’s disease (PD) patients caused a resur-
gence of interest in pallidotomy as an option of treatment. However, postoperative complications such as
speech disorders can occur. Purpose: The aim of this study is to evaluate the acoustic voice in PD patients,
before and after posteroventral pallidotomy. Method: Twelve patients with PD were submitted to
neurological and voice assessments during the off and on phases, in the pre-operative, 1st and 3rd post-
operative months. The patients were evaluated with the UPDRS and the vocal acoustic parameters - f0,
NHR, jitter, PPQ, Shimmer, APQ (using the software MultiSpeech - Kay Elemetrics - 3700). Results: The off
phase UPDRS scores revealed a tendency to improvement at the 1st month and the off phase worsened. The
shimmer and APQ improved. Conclusion: This study shows that pallidotomy has little improvement on
functional use of communication of PD patients.
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Parametros acústicos da voz em pacientes com doença de Parkinson submetidos a palidotomia
posteroventral
RESUMO - O uso prolongado da levodopa na doença de Parkinson (DP) pode ocasionar alterações em seu
rendimento e possibilitou o interesse no ressurgimento da palidotomia. Contudo, complicações pós-opera-
tórias podem ocorrer. Objetivo: O presente estudo tem por objetivo avaliar alguns parâmetros acústicos
da voz de pacientes com DP pré e pós a realização da palidotomia posteroventral Metodo: foram avalia-
dos 12 pacientes com PD submetidos a avaliação neurológica e da voz durante as fases off e on do uso da
levodopa, nos momentos pré-operatório, no primeiro e no terceiro mês pós-operatório. Os pacientes
foram avaliados com base na escala UPDRS - item motor - e por meio dos parâmetros acústicos da voz - f0,
NHR, jitter, PPQ, Shimmer, APQ (usando o software MDVP - Kay Elemetrics - 3700). Resultados: Na fase
off o escore UPDRS revelou tendência de melhora no 1o pós-operatório e na fase on piora. Os parâmetros
acústicos shimmer e APQ apresentaram melhora. Conclusão: Este estudo mostrou que a palidotomia resul-
ta em discreta melhora no uso funcional da comunicação dos pacientes com DP. 
PALAVRAS-CHAVE: doença de Parkinson, palidotomia, voz.
The options of treatment in Parkinson’s disease
(PD) are, among other drugs, levodopa therapy, sur-
gical treatment, such as pallidotomy and thalam-
otomy, fetal cell transplant and deep brain stimula-
tion, besides physical therapy, psychotherapy, and
speech therapy. Levodopa remains the mainstay
treatment of PD patients but long term complica-
tions, such as motor fluctuations and dyskinesias are
quite frequent1. Some authors suggest that levodo-
pa treatment interferes in a positive way in com-
munication symptoms. Jiang et al.2 and Sanabria
et al.3 observed improvement in the acoustic (F0,
jitter, SPI e FTRI) and glottographic parameters af-
ter the administration of levodopa. In an electro-
myography study, Gallena et al.4 observed an in-
crease in the activity of the thyro-aritenoid mus-
cle after the administration of levodopa.
Posteroventral pallidotomy (PVP) consists of
the lesion of the internal pallidum (Gpi) with radio-
frequency lesions in its sensory-motor territory. Pos-
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teroventral pallidotomy can improve the cardinal
motor signals, and also reduce dyskinesias and drug-
related motor fluctuations5,6. Buck and Cooper7
studied the speech after chemopallidectomy or
occlusion of the anterior coroid artery, and observed
a reduction of the diadochokinetic rate of the vo-
cal folds. Schulz et al8 studied the effect of pallido-
tomy on selected voice and speech characteristics
of 6 PD patients. Acoustic measurements were ana-
lyzed pre-pallidotomy and again at 3 months fol-
lowing surgery. Preliminary findings indicated that
all participants demonstrated positive changes in
at least one acoustic measure; 2 patients consistent-
ly demonstrated positive changes in phonatory and
articulatory measures, whereas 3 patients did not
consistently demonstrate positive changes after sur-
gery. The results are discussed in relation to differ-
ential effects observed among the participants. In
2000, Schulz et al.9 perceived that vocal intensity
was greater after PVP in patients that showed mild
disarthrophonia.
The aim of this study is to investigate the chan-
ges in acoustic voice parameters in patients with
idiopathic PD, before and after posteroventral
pallidotomy, during the off and on phases of the
levodopa effect. 
METHOD
Sample selection criteria – Patients were selected from
the Movement Disorders Clinic of the Department of
Neurology of the Universidade Federal de São Paulo. They
were clinically diagnosed as having the idiopathic PD,
according to the criteria defined by Ward, Gibb10 and
had to have indication for posteroventral pallidotomy
surgery, with the following criteria: 1) physical incapaci-
ty for daily life activities (DLA), in spite of the use of ade-
quate doses and combinations of antiparkinsonian drugs;
2) presence of fluctuation or disabling dyskinesias with
antiparkinsonian therapy. The exclusion criteria were
based on the presence of moderate or severe cognitive
implications (evaluated by the unit’s neurologists). PVP
was performed contralateral to the most affected side
of the body. In symmetrically affected cases, PVP was per-
formed on the side that could bring the most benefit to
the patient, taking into account whether he was right
or left-handed. Based on the prior neurological evalua-
tions, the following surgical targets were indicated: three
right pallidotomies and nine left pallidotomies (Table 1). 
Patients – Twelve patients were included in this study.
Five were females and seven males. The average age of
the group was 62.4 years (ranging from 50 to 71 years
old) The average disease duration of disease onset was
13.5 years (ranging from 7 to 32 years). Disarthrophonia
was considered as moderate in eight and mild in four
(Table 1). 
Surgical procedure – All patients were submitted to
surgical procedures as described by Aguiar et al.11
Neurological evaluation – All individuals were rated
by the Unified Parkinson’s Disease Rating Scale - UPDRS12,
focusing on the motor score (items 18 to 31) in the on and
off phases of the levodopa effect. 
Patients were submitted to neurological evaluation
in a period ranging from one week to one month before
the surgical procedure (pre-op), after 30 (1st po) and 90
(3rd po) days of the surgical procedure. All individuals
Table 1. Characterization of the sample according to gender, age, time of disease and side of
posteroventral pallidotomy and dysartrophonia degree pre- and post-surgery.
Patient Gender Age Time of Side of
(years) disease (years) the surgery Dysartrophonia degree
Pre-surgery Post-surgery
1 M 71 32 R moderate moderate
2 F 60 10 L moderate mild
3 M 50 15 L moderate moderate
4 M 61 8 L moderate moderate
5 F 71 17 L mild mild
6 M 69 10 R moderate severe
7 M 60 20 L mild mild
8 M 54 7 L mild moderate
9 F 58 19 L mild mild
10 M 55 8 L moderate mild
11 F 71 6 L moderate severe
12 F 69 10 R moderate moderate
M, male; F, female; R, right; L, left.
 
22 Arq Neuropsiquiatr 2005;63(1)
received levodopa treatment, with doses varying accord-
ing to each patient’s requirements. Since all the individ-
uals received levodopa therapy, the option was made to
evaluate them in the on and off phases. The definition
of the on and off phases was adapted from that sugges-
ted by the Core Assessment Program for Intracerebral
Transplantation13. The evaluation in the off phase was
performed in the morning period, at least 12 hours after
the last administration of levodopa, while the other anti-
parkinsonian drugs were maintained. Some patients sho-
wed great incapacity if they did not receive the levodo-
pa dose, being unable to get to the hospital for evalua-
tion in the off phase. They were asked then to return for
evaluation at another time. However, this was not possi-
ble for some patients and the evaluation of the off phase
was not done without excluding the patient from the
sample. For this reason, patients 4, 8 e 11 were not asse-
ssed on the off phase of third month postoperative eva-
luation. 
After evaluation in the off phase, the patient was re-
quested to take his or her usual dose of levodopa, and
underwent a new evaluation during the on phase, ap-
proximately 40 minutes to 2 hours after the ingestion.
Sometimes, when the patient did not reach an on phase,
his evaluation was repeated under the expected condi-
tions on another day. In patients who did not reach the
on phase, this evaluation was not done without exclud-
ing them from the sample. Patients 8 and 11 were not
assessed during the on phase of third month post-oper-
ative evaluation.
Acoustic voice measurements – After the neurologi-
cal evaluation, the oral communication evaluation was
carried on. We recorded the following phonation tasks:
the emission of the oral vowel, open and central /a/, like
father, isolated and sustained in the habitual pitch and
loudness and in comfortable way. The patients’ phona-
tion tasks were recorded by a digital Mini-Disc recorder,
model MDS-520 (Sony trademark), unidirectional; a ste-
reo microphone, model SM-58 (Shure trademark), sited
15 cm distant from the speaker’s mouth, and a 74 minute
mini disk (Sony trademark). Due to the motor and bal-
ance difficulties and the presence of disabling dyskine-
sias in some patients, all of them were asked to be sitting
while recording their tasks. 
The Multi-dimensional Voice Program software, mod-
el 5105 (Kay Elemetrics Corp.) performed the compute-
rized acoustic analysis. The fundamental frequency mea-
surements (F0), frequency (jitter and PPQ) and intensity
perturbation (Shimmer and APQ) and noise (NHR) were
extracted from the emission of central, low, open oral vow-
el /a/, isolated and sustained in the habitual pitch and loud-
ness. The most stable portion of an average of 3 seconds
was selected as vocal sample and whenever possible, the
beginning and the end of the emission were eliminated. 
Statistical method – The analysis of variance for a ran-
domized block design test was used to analyze the lev-
odopa dose over the period of time, to compare the glob-
al UPDRS motor scores and the acoustic measurement.
A 0.05 significance level was considered for all analyses.
Reliability analysis was performed using the intraclass
correlation coeficient test and was assessed by remea-
suring 80% of the data of acoustic measurement. Cor-
relation coefficient ranged from 0.88 to 0.9979. The
score of UPDRS III - scale was not submitted to reliabil-
ity analysis.
RESULTS
The selected parameters were analyzed in-
groups and the data were expressed by the avera-
ge of the total sample.
In general, the surgeries performed did not in-
duced a reduction in the daily dose of levodopa
(pre-op=625mg, 1st po=640mg, 3rd=688mg -
p=0.912). However, when comparing the UPDRS
(Part III- motor scores), we noted a trend towards
improvement between the pre-op and the 1st po
in the off phase (p=0.052). In the on phase, the UP-
DRS scores showed a statistically significant dete-
rioration (p=0.007*) (Fig 1). 
The acoustic measurements of the voice in the
off phase at the pre-op period compared with 3rdpo
revealed statistically significant differences, special-
ly in F0, despite the small increase of 16Hz observed
in the 3rd po, this difference was statistically signifi-
cant (p=0.009*). The amplitude perturbation meas-
Fig 1. Data of the global motor score, in the pre-operative, in
the 1st moth and 3rd month postoperative. Pre, pre-operative
period; 1o, first post-operative month; 3o, third post-operative
month.
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urements shimmer and APQ were reduced, char-
acterized by a statistically significant improvement
up to the 3rd po (p=0.038* and p=0.027*, respec-
tively) (Fig 2).
High values were found in the frequency pertur-
bation measurements (jitter e PPQ) on the all phas-
es and periods (Fig 2). The noise NHR measurement
revealed slightly increased values. Both measure-
ments presented some reduction at the postoperati-
ve period, although not a statistically significant one
(jitter: p=0.212; PPQ: p=0.159; NHR p=0.071) (Fig 2). 
DISCUSSION
After the PVP we observed no change in the se-
verity of dysarthrophonia in seven subjects, worse-
ning in three and improvement in only two, sugges-
ting that PVP neither interfere in the voice nor in
the speech of these patients. The UPDRS (Part III-
motor score) was used because it allows data com-
parisons between different studies, as it is a wide-
ly used scale. The mean UPDRS score was lower after
PVP, which is in accordance with the literature5,11,14.
The different studies that reported neurological
evaluations in the off and on phase observed an im-
provement only in the off phase5,11,14-16. Ondo et
al14 speculated that the improvement in the off
phase is consistent with the traditional model of the
basal ganglia physiology in PD, which determines
the presence of tonic thalamic hypo activity result-
ing from the excessive inhibition induced by the in-
ternal palladium. The Gpi efferent is somatotopical-
ly connected to the ventro-lateral thalamus via ansa
lenticular (anteriorly) and the lenticular fascicule
(posteriorly). Excessive Gpi activity is (believed to
be) the result of a reduction of striatal inhibition
(direct via) and of the increase in subthalamicex-
citation (indirect via). 
A small change was observed in voice assessment,
although it revealed values lower than those obser-
ved in the off phase. According to our clinical expe-
rience and some studies17, the effect of levodopa
on the symptoms of voice and speech still appears
to require more detailed studies, bearing in mind
the great variability of symptoms shown by patients
treated with this drug. The changes observed in
the off phase, in the neurological, voice assessment
suggest that the ideal period for evaluating motor
symptoms and the interference of voice treatment
in PD is in the off phase.
With regard to F0, studies show F0 to be higher
in men and lower in women with PD18. However,
this study did not show evidence of changes in the
Fig 2. Data of the acoustic measurements: F0, jitter, PPQ, shimmer, APQ and NHR, in the pre-operative, 1st month
and 3rd month postoperative, on the off and on phases.
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usual frequency range, which is similar to the study
of Ramig et al.19. In the studied periods, it was ob-
served an increase in F0 as Schulz et al.8 that obser-
ved an increase in the fundamental frequency in
three out of six cases evaluated. 
The laryngeal physiopathology in PD can be con-
sidered in this case. Laryngeal changes are frequen-
tly explained by the presence of bradykinesia or ri-
gidity. Hirose, and Joshita18 observed in a single indi-
vidual the loss of reciprocal suppression of the thy-
roarytenoid muscle during inspiration, which is indi-
cative of rigidity. Baker et al.20 attributed hypokine-
sia and bradykinesia to the presence of changes in
the laryngeal function. Thus, the increase in F0 may
be associated with the increase in loudness. There
is an intimate relationship between F0 and vocal in-
tensity; although increases in intensity are meas-
ured by greater glottal coaptation and activity of
the respiratory mechanism, variations in intensity
are dependent on the frequency and vice-versa. Re-
garding the evaluation of vocal intensity, some studi-
es described a reduction in loudness after PVP5,8,15, whi-
le Laitinen et al.6 observed an increase. Schulz et al.8
did not observe a correlation between the increase
of F0 and the increase in vocal intensity. They only
perceived that vocal intensity was greater after PVP
in patients that showed mild dysarthrophonia9.
Frequency perturbation measurements changes
are found in PD patients19; NHR also showed increa-
sed values. One could suppose that the NHR would
be ideal in evaluating changes in the glottal source
and less sensitive in analyzing in the dysarthropho-
nia. The amplitude perturbation shimmer and APQ
measurements improved, though without reach-
ing normality. The surgical procedure may have hel-
ped in the greater control of the phonation system.
However, the improvement in measurement was
not sufficient to interfere in the functional use of
communication in PD patients. The frequency per-
turbation and intensity measurements represent
the efficiency of motor control of the laryngeal sys-
tem in maintaining an emission as stable as possi-
ble, apart from correlating the changes in glottal coap-
tation and the presence of roughness and breath-
ness in voice21. Nevertheless, Kent et al.22 discussed
the feasibility of correlating the acoustic measure-
ments with the phonation characteristics of the au-
ditory perceptual analysis in the neurological dys-
phonia. So it remains unknown whether the acous-
tic properties always correlate to the perceptive des-
criptions.
Analyzing the surgical interference in the UPDRS
scores (Part III) and the voice parameters, slight dif-
ferences were observed throughout the postopera-
tive periods. The total average score of the UPDRS,
in the off phase revealed an improvement in the
1st po and a small deterioration in the 3rd po. Ho-
wever, in relation to the voice and speech parame-
ters evaluated, the averages showed statistically sig-
nificant improvement only when the pre surgery
period was compared to the 3rd po. 
Discrepant data regarding surgical interference
with the motor symptoms of the members and voice
and speech were also observed by Buck, and Co-
oper7, who showed similar improvement of tremor,
rigidity and speech in only 20.0% of the patients.
Some questions may be raised. The variation in
hypokinetic dysarthrophonia and the neurophysi-
ological and neuroanatomical differences of the
voice and speech sensorymotor organization in rela-
tion to the limbs may distinctly affect individuals
with PD and thus, generate differences in the res-
ponses to the surgical procedure23.
In conclusion, this study showed improvement
in some selected phonation parameters, but the sur-
gical procedure did not promote major facilitation
of the functional use of communication, since no
improvement was observed in dysarthrophonia. This
study revealed slight changes on voice parameters
evaluated after unilateral posteroventral pallido-
tomy. According to some authors, the changes in
voice and speech may be a consequence of the size
of the lesion and the perilesional edema in unilat-
eral surgical interventions, as well as of different
neurophysiologic and neuroanatomical mecha-
nisms responsible for sensory-motor organization
of voice and speech in relation to limbs15,23. Howe-
ver we found no correlation between the side of
the lesion and worsening of voice, as observed by
Wang and colleagues24.
Numerous researches and modern techniques
have been employed in the search for improving
PD treatment. However, nowadays the therapeu-
tic options present inherent limitations to the dise-
ase and the treatment itself. Thus, recent and con-
trolled studies have shown that changes in voice
and speech in PD patients seem to respond satis-
factorily to speech therapy25,26. Therefore, studies
that analyze specific effects of different treatment
interventions help us not only to understand PD,
but also to define medical and speech therapy .
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